Keep my session open?
Ending In 
The session is expired
Your session has expired. For your security, we have logged you out.
Would you like to log in again?

Bioprocessing solutions for vaccines

The development of vaccines has primarily targeted infectious diseases, but new developments are now focusing on immuno-oncology applications. The production of influenza vaccines is moving away from the use of fertilized eggs to bioprocessing applications employing primary cells or cell lines.

Maintaining the integrity and activity of the vaccine during upstream production to downstream purification and through final fill can be successfully achieved with products from VWR, part of Avantor.

VWR, part of Avantor supplies a broad range of raw materials and ancillary materials for early discovery phase through product development, pre-clinical, scale-up, and commercial manufacturing. Choose from a range of animal sera products used to enhance attachment and growth of adherent cells, cell culture media and transfection reagents, excipients used in drug product formulation, and single-use product assemblies to enable aseptic fluid transfer throughout the process.

Vaccines workflow

Take the next step

Ready to get started?

Our Bioprocessing Solutions team can help!

Yes, let's get started!